Business Context and Reporting Period
Company: TriSalus Life Sciences, Inc. (TLSI)
Filing Type: Form 8-K (Current Report)
Report Date: August 12, 2025
Reporting Period: Quarter ended June 30, 2025
Business Update: The Company issued a press release on August 12, 2025, providing a business update and announcing financial results for the quarter ended June 30, 2025. The full text of this press release is included as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not contain specific numerical values for the following metrics:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to Exhibit 99.1 for this information.
Guidance, Outlook, and Risks
Management Commentary: The Company announced a business update and financial results for the quarter ended June 30, 2025, via a press release incorporated by reference.
Guidance and Outlook: Specific forward-looking guidance is not detailed in the 8-K text; refer to Exhibit 99.1.
Risks and Contingencies: No specific risks or contingencies are enumerated in the provided text.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 12, 2025) for actual revenue, net income, and cash position figures.
- Verify the specific details of the "business update" mentioned in Item 2.02.
- Check for any updated financial guidance or operational milestones in the referenced press release.
- Confirm the status of the Company's Emerging Growth Company election and any related accounting standard transitions.